CAS 59-92-7 levodopa, mucuna pruriens extract 98% l-dopa

L-DOPA (L-3,4-dihydroxyphenylalanine; INN levodopa; trade names Sinemet, Parcopa, Atamet, Stalevo, Madopar, Prolopa, etc.) is a naturally occurring dietary supplement and psychoactive drug found in certain kinds of food and herbs (e.g., Mucuna pruriens, or velvet bean), and is synthesized from the amino acid L-tyrosine in the mammalian body and brain.
L-DOPA is the precursor to the neurotransmitters dopamine, norepinephrine (noradrenaline), and epinephrine (adrenaline) collectively known as catecholamines.
Aside from its natural and essential biological role, L-DOPA is also used in the clinical treatment of Parkinson's disease and dopamine-responsive dystonia. When used in a pharmaceutical context, the INN designation 'levodopa' is normally used.

Function

1.Mucuna Pruriens Extract is anti-paralysis agitans. Through the blood-brain barrier into the brain tissue, but by the decarboxylation of dopa decarboxylase into dopamine, play a role.
2.Mucuna Pruriens Extract use for essential tremor and paralysis paralysis agitans syndrome of non-drug immunogenicity, and in better light, severe, or the elderly poor.
3.Mucuna Pruriens Extract can treat parkinsonism and Pakinsonism syndrome, hepatic coma,hub functions to improve the patient awake, symptom improvement.
4.Mucuna Pruriens Extract can promote sleep,improve immune system.
5.Mucuna Pruriens Extract can Increase bone density and reversal of osteoporosis,increase muscle strength,enhance libido and sexual performance.

Application

1.Mucuna Pruriens Extract can be used as dietary supplements.
2.Mucuna Pruriens Extract is used as a component in marine adhesives used by pelagic life.
3.Mucuna Pruriens Extract can promote muscle growt and increased bone density and reversal of osteoporosis.
4.Mucuna Pruriens Extract increase bone density and reversal of osteoporosis,increase muscle strength,enhance libido and sexual performance.
5.In clinical use, Mucuna Pruriens Extract is administered in the management of Parkinson's disease and dopa-responsive dystonia.
6.For essential tremor and paralysis paralysis agitans syndrome of non-drug immunogenicity, and in better light, severe, or the elderly poor.